Useful For

Risk stratification of patients with multiple myeloma, which can
assist in determining treatment and management decisions

Risk stratification of patients with newly diagnosed multiple
myeloma

Reflex Tests

Test ID

Reporting Name

Available Separately

Always Performed

MPCPD

mSMART Eval, PCPD, FISH

No

No

Testing Algorithm

Based on the flow cytometric analysis and presence of greater
than or equal to 0.1% monotypic plasma cells, the MPCPD / mSMART,
Plasma Cell Proliferative Disorder (PCPD), FISH test will be
reflexed and performed at an additional charge.

See Laboratory Screening Tests for Suspected Multiple Myeloma in
Special Instructions.

Special Instructions

Method Name

Flow Cytometry/DNA Content/Cell Cycle Analysis

Reporting Name

mSMART Algorithmic Testing, BM

Specimen Type

Bone Marrow

Advisory Information

This test should be ordered at diagnosis of Multiple Myeloma and
when the client wants MPCPD / mSMART, Plasma Cell Proliferative
Disorder (PCPD), FISH to be reflexed based on the Laboratory
Screening Tests for Suspected Multiple Myeloma algorithm.

Day(s) and Time(s) Performed

Analytic Time

1 day (MSMRT only) 11 days (with MPCPD)

Specimen Retention Time

14 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed using an analyte specific reagent. Its
performance characteristics were determined by Mayo Clinic in a
manner consistent with CLIA requirements. This test has not been
cleared or approved by the U.S. Food and Drug Administration.